Related Experiment Videos
Elevated myelin basic protein levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia
Insights
Elevated myelin basic protein (MBP) in cerebrospinal fluid may indicate active myelin breakdown in children with acute lymphoblastic leukemia, even before symptoms appear. This suggests MBP is a sensitive biomarker for early detection of central nervous system involvement.
Area of Science:
- Neuroscience
- Pediatric Oncology
- Biochemistry
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Central nervous system (CNS) involvement in ALL can lead to serious complications, including leukoencephalopathy.
- Myelin basic protein (MBP) is a key component of myelin and its release can indicate myelin breakdown.
Purpose of the Study:
- To investigate the presence of active myelin breakdown in children with ALL using cerebrospinal fluid (CSF) myelin basic protein (MBP) levels.
- To determine if elevated MBP levels can serve as an early indicator of CNS involvement in asymptomatic children with ALL.
Main Methods:
- Cerebrospinal fluid (CSF) samples were collected from 70 children diagnosed with acute lymphoblastic leukemia (ALL).
- Serial MBP levels were measured in 53 asymptomatic children from the time of diagnosis.
- MBP levels were also assessed in children with diagnosed leukoencephalopathy and meningeal leukemia for comparison.
Main Results:
- Abnormal elevations of MBP were detected in 15.1% (8 out of 53) of asymptomatic children with ALL.
- Six of these eight children showed elevated MBP before receiving any CNS-directed therapy.
- Children with clinical leukoencephalopathy had abnormal MBP, while those with meningeal leukemia did not.
Conclusions:
- Elevated MBP levels in CSF may indicate active myelin breakdown in children with ALL, potentially preceding clinical symptoms.
- MBP determination in CSF could be a valuable biomarker for early detection of subclinical CNS involvement in pediatric ALL.
- Further long-term observations are ongoing to fully understand the implications of these findings.
Abstract:
Cerebrospinal fluid was examined from 70 children with acute lymphoblastic leukemia for evidence of active myelin breakdown based on the release of myelin basic protein (MBP). Fifty-three asymptomatic children were followed from diagnosis with serial MBP determinations. Eight (15.1%) of 53 children had abnormal elevations of MBP, six of eight before receiving presymptomatic central nervous system therapy. Long-term observations are in progress. For comparison, six children with clinical and radiologic findings of leukoencephalopathy had abnormal MBP determinations, whereas no abnormalities were detected in 11 children with meningeal leukemia.